Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FDY-5301 in acute myocardial infarction
NCT03470441Phase 2Completed
- Sponsor
- Faraday Pharmaceuticals
- Start
- Oct 2017
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of Sodium iodide in acute myocardial infarction (AMI), sponsored by Faraday Pharmaceuticals. Started Oct 2017; status: completed.
02
Drugs
Sodium iodide
03
Conditions
acute myocardial infarction (AMI)
Beyond the preview
Go deeper on NCT03470441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03470441.